SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-014762
Filing Date
2020-06-12
Accepted
2020-06-12 08:10:43
Documents
3
Period of Report
2020-06-12

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea122989-6k_biondvax.htm 6-K 10870
2 PRESS RELEASE DATED JUNE 12, 2020 ea122989ex99-1_biondvax.htm EX-99.1 85563
3 GRAPHIC ex99-1_001.jpg GRAPHIC 3894
  Complete submission text file 0001213900-20-014762.txt   102926
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 20958916
SIC: 2836 Biological Products, (No Diagnostic Substances)